Jeevan Kumar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Newly Diagnosed

Ejection Fraction

Top Venues

Indian journal of cancer

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Manthan Kathrotiya, Vivek Radhakrishnan, Saurabh J Bhave, Arijit Nag, Neeraj Arora, Mita Roychoudhry, Mayur Parihar, Deepak Mishra, Reena Nair, Mammen Chandy, Jeevan Kumar
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature. Indian journal of cancer 60 (4) (2024)
Manthan Kathrotiya, Vivek Radhakrishnan, Saurabh J Bhave, Arijit Nag, Neeraj Arora, Mita Roychoudhry, Mayur Parihar, Deepak Mishra, Reena Nair, Mammen Chandy, Jeevan Kumar
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature. Indian journal of cancer 60 (4) (2024)
Manthan Kathrotiya, Vivek Radhakrishnan, Saurabh J Bhave, Arijit Nag, Neeraj Arora, Mita Roychoudhry, Mayur Parihar, Deepak Mishra, Reena Nair, Mammen Chandy, Jeevan Kumar
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature. Indian journal of cancer 60 (4) (2024)
Laura Cicconi, Maria Luisa Moleti, Pau Montesinos, Eduardo Rego, Hong Hu Zhu, Hiroyuki Takahashi, Michael Dworzak, Elihu Estey, Anthony Schwarer, Aleksandra Holowiecka, Ombretta Annibali, Roberto Castelli, Milena Mirabile, Mario Angelini, Vladimir Lj Lazarevic, Jeevan Kumar, Giuseppe Avvisati, Carmelo Gurnari, Franco Locatelli, Maria Teresa Teresa Voso, Miguel Angel Sanz, Francesco Lo-Coco, Oussama Abla
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants. Blood cancer journal 11 (10) (2021)